The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors ...
The Food and Drug Administration (FDA) has now identified the previous recall of certain FreeStyle Libre glucose monitor ...
Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...
The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...
Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths ...
The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...
Instead of making life easier for medical device companies, the FDA’s new wearables guidance makes the market more complex.
County officials are replicating a sand placement project that was first introduced in 2006, in response to the 2004 hurricanes, to address the “severely eroded” beaches that resulted in “massive ...
TORONTO, ON / ACCESS Newswire / January 27, 2026 / Biomind Labs Inc. ("Biomind" or the "Company") (CBOE:BMND)(OTC PINK:BMNDF)(FRA:3XI), a clinical-stage biopharmaceutical company focused on ...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. HALIFAX, Nova Scotia, Jan.
Many aspects of neuronal function are regulated by changes in the concentration of intracellular free Ca 2+. To fully understand how this occurs, an appreciation is needed of how changes in the ...
Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results